Results for tag: "Endari"

The Endari market is a segment of the hematological drugs industry that focuses on treatments for sickle cell disease. Endari is a medication that helps to reduce the frequency of painful crises and other complications associated with the condition. It is the only FDA-approved drug for sickle cell disease in adults and children five years of age and older. Endari works by increasing the levels of fetal hemoglobin, which helps to reduce the sickling of red blood cells. The Endari market is a relatively small segment of the hematological drugs industry, but it is an important one. It is estimated that sickle cell disease affects millions of people worldwide, and Endari is the only approved treatment for the condition. Companies in the Endari market include Emmaus Medical, Inc., which manufactures and markets the drug, as well as other pharmaceutical companies that are researching and developing new treatments for sickle cell disease. Additionally, there are a number of organizations that provide support and resources to those living with the condition. Show Less Read more